Chemical Space Overlap with Critical Protein–Protein Interface Residues in Commercial and Specialized Small‐Molecule Libraries

There is growing interest in the use of structure‐based virtual screening to identify small molecules that inhibit challenging protein–protein interactions (PPIs). In this study, we investigated how effectively chemical library members docked at the PPI interface mimic the position of critical side‐chain residues known as “hot spots”. Three compound collections were considered, a commercially available screening collection (ChemDiv), a collection of diversity‐oriented synthesis (DOS) compounds that contains natural‐product‐like small molecules, and a library constructed using established reactions (the “screenable chemical universe based on intuitive data organization”, SCUBIDOO). Three different tight PPIs for which hot‐spot residues have been identified were selected for analysis: uPAR⋅uPA, TEAD4⋅Yap1, and CaVα⋅CaVβ. Analysis of library physicochemical properties was followed by docking to the PPI receptors. A pharmacophore method was used to measure overlap between small‐molecule substituents and hot‐spot side chains. Fragment‐like conformationally restricted small molecules showed better hot‐spot overlap for interfaces with well‐defined pockets such as uPAR⋅uPA, whereas better overlap was observed for more complex DOS compounds in interfaces lacking a well‐defined binding site such as TEAD4⋅Yap1. Virtual screening of conformationally restricted compounds targeting uPAR⋅uPA and TEAD4⋅Yap1 followed by experimental validation reinforce these findings, as the best hits were fragment‐like and had few rotatable bonds for the former, while no hits were identified for the latter. Overall, such studies provide a framework for understanding PPIs in the context of additional chemical matter and new PPI definitions.

[1]  Stuart L. Schreiber,et al.  Chemical probes and drug leads from advances in synthetic planning and methodology , 2018, Nature Reviews Drug Discovery.

[2]  S. Meroueh,et al.  Mimicking Intermolecular Interactions of Tight Protein–Protein Complexes for Small‐Molecule Antagonists , 2017, ChemMedChem.

[3]  Samy O Meroueh,et al.  A Computational Investigation of Small-Molecule Engagement of Hot Spots at Protein-Protein Interaction Interfaces , 2017, J. Chem. Inf. Model..

[4]  S. Meroueh,et al.  Small Molecules Engage Hot Spots through Cooperative Binding To Inhibit a Tight Protein-Protein Interaction. , 2017, Biochemistry.

[5]  Paul D Leeson,et al.  Molecular inflation, attrition and the rule of five. , 2016, Advanced drug delivery reviews.

[6]  H. Willems,et al.  Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery. , 2016, Journal of medicinal chemistry.

[7]  D. Scott,et al.  Small molecules, big targets: drug discovery faces the protein–protein interaction challenge , 2016, Nature Reviews Drug Discovery.

[8]  Min Liu,et al.  Re-engineering the Immune Response to Metastatic Cancer: Antibody-Recruiting Small Molecules Targeting the Urokinase Receptor. , 2016, Angewandte Chemie.

[9]  John J. Irwin,et al.  ZINC 15 – Ligand Discovery for Everyone , 2015, J. Chem. Inf. Model..

[10]  Olivier Sperandio,et al.  iPPI-DB: an online database of modulators of protein–protein interactions , 2015, Nucleic Acids Res..

[11]  Florent Chevillard,et al.  SCUBIDOO: A Large yet Screenable and Easily Searchable Database of Computationally Created Chemical Compounds Optimized toward High Likelihood of Synthetic Tractability , 2015, J. Chem. Inf. Model..

[12]  Jeremy R. Duvall,et al.  Utilizing diversity-oriented synthesis in antimicrobial drug discovery. , 2014, Future medicinal chemistry.

[13]  J. Wells,et al.  Small-molecule inhibitors of protein-protein interactions: progressing toward the reality. , 2014, Chemistry & biology.

[14]  Jean-Luc Poyet,et al.  Drug-Like Protein–Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology , 2014, Molecular informatics.

[15]  Tom L. Blundell,et al.  TIMBAL v2: update of a database holding small molecules modulating protein–protein interactions , 2013, Database J. Biol. Databases Curation.

[16]  M. Congreve,et al.  Ask the experts: past, present and future of the rule of five. , 2013, Future medicinal chemistry.

[17]  Woody Sherman,et al.  Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments , 2013, Journal of Computer-Aided Molecular Design.

[18]  L. Lam,et al.  ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets , 2013, Nature Medicine.

[19]  Jason E. Gestwicki,et al.  Features of protein–protein interactions that translate into potent inhibitors: topology, surface area and affinity , 2012, Expert Reviews in Molecular Medicine.

[20]  David R Spring,et al.  Diversity-oriented synthesis: producing chemical tools for dissecting biology. , 2012, Chemical Society reviews.

[21]  Jing Li,et al.  Targeting multiple conformations leads to small molecule inhibitors of the uPAR·uPA protein-protein interaction that block cancer cell invasion. , 2011, ACS chemical biology.

[22]  Jan H. Jensen,et al.  PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions. , 2011, Journal of chemical theory and computation.

[23]  Sivaraman Dandapani,et al.  Grand challenge commentary: Accessing new chemical space for 'undruggable' targets. , 2010, Nature chemical biology.

[24]  Nathan T. Ross,et al.  An aldol-based build/couple/pair strategy for the synthesis of medium- and large-sized rings: discovery of macrocyclic histone deacetylase inhibitors. , 2010, Journal of the American Chemical Society.

[25]  Jonathan G. Lees,et al.  Transient protein-protein interactions: structural, functional, and network properties. , 2010, Structure.

[26]  Woody Sherman,et al.  Analysis and comparison of 2D fingerprints: insights into database screening performance using eight fingerprint methods , 2010, J. Cheminformatics.

[27]  Woody Sherman,et al.  Large-Scale Systematic Analysis of 2D Fingerprint Methods and Parameters to Improve Virtual Screening Enrichments , 2010, J. Chem. Inf. Model..

[28]  David Calkins,et al.  Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution , 2010, J. Comput. Aided Mol. Des..

[29]  Philippe Roche,et al.  Atomic Analysis of Protein-Protein Interfaces with Known Inhibitors: The 2P2I Database , 2010, PloS one.

[30]  Olivier Sperandio,et al.  Designing Focused Chemical Libraries Enriched in Protein-Protein Interaction Inhibitors using Machine-Learning Methods , 2010, PLoS Comput. Biol..

[31]  Fei Chen,et al.  Structural insights into the YAP and TEAD complex. , 2010, Genes & development.

[32]  W. Hong,et al.  Structural basis of YAP recognition by TEAD4 in the hippo pathway. , 2010, Genes & development.

[33]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[34]  David R Spring,et al.  Is synthesis the main hurdle for the generation of diversity in compound libraries for screening? , 2009, Expert opinion on drug discovery.

[35]  Andreas Bender,et al.  The discovery of antibacterial agents using diversity-oriented synthesis. , 2009, Chemical communications.

[36]  Chong Li,et al.  Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX , 2009, Proceedings of the National Academy of Sciences.

[37]  Dima Kozakov,et al.  Fragment-based identification of druggable 'hot spots' of proteins using Fourier domain correlation techniques , 2009, Bioinform..

[38]  Solène Grosdidier,et al.  Identification of hot-spot residues in protein-protein interactions by computational docking , 2008, BMC Bioinformatics.

[39]  Adam Nelson,et al.  Natural products as an inspiration in the diversity-oriented synthesis of bioactive compound libraries , 2008, Natural product reports.

[40]  Andreas Bender,et al.  Diversity-oriented synthesis; a spectrum of approaches and results. , 2008, Organic & biomolecular chemistry.

[41]  Karl E Duderstadt,et al.  Alanine-scanning mutagenesis defines a conserved energetic hotspot in the CaValpha1 AID-CaVbeta interaction site that is critical for channel modulation. , 2008, Structure.

[42]  Jeremy R. Greenwood,et al.  Epik: a software program for pKa prediction and protonation state generation for drug-like molecules , 2007, J. Comput. Aided Mol. Des..

[43]  David E. Shaw,et al.  PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results , 2006, J. Comput. Aided Mol. Des..

[44]  Steven L Dixon,et al.  PHASE: A Novel Approach to Pharmacophore Modeling and 3D Database Searching , 2006, Chemical biology & drug design.

[45]  P. Hajduk,et al.  Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesis. , 2006, Journal of medicinal chemistry.

[46]  Richard A. Friesner,et al.  Integrated Modeling Program, Applied Chemical Theory (IMPACT) , 2005, J. Comput. Chem..

[47]  Derek S. Tan,et al.  Diversity-oriented synthesis: exploring the intersections between chemistry and biology , 2005, Nature chemical biology.

[48]  Stephen J Haggarty,et al.  The principle of complementarity: chemical versus biological space. , 2005, Current opinion in chemical biology.

[49]  Paul D Leeson,et al.  Time-related differences in the physical property profiles of oral drugs. , 2004, Journal of medicinal chemistry.

[50]  B. Honig,et al.  A hierarchical approach to all‐atom protein loop prediction , 2004, Proteins.

[51]  Hege S. Beard,et al.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.

[52]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[53]  J. Janin,et al.  A dissection of specific and non-specific protein-protein interfaces. , 2004, Journal of molecular biology.

[54]  David R Spring,et al.  Diversity-oriented synthesis; a challenge for synthetic chemists. , 2003, Organic & biomolecular chemistry.

[55]  Stephen R. Johnson,et al.  Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.

[56]  G. Weiss,et al.  Rapid mapping of protein functional epitopes by combinatorial alanine scanning. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[57]  A. Bogan,et al.  Anatomy of hot spots in protein interfaces. , 1998, Journal of molecular biology.

[58]  U. Weidle,et al.  Systematic mutational analysis of the receptor-binding region of the human urokinase-type plasminogen activator. , 1996, European journal of biochemistry.

[59]  Kyoung Tai No,et al.  Natural products used as a chemical library for protein-protein interaction targeted drug discovery. , 2018, Journal of molecular graphics & modelling.

[60]  C G M Wilson,et al.  Small-molecule inhibitors of IL-2/IL-2R: lessons learned and applied. , 2011, Current topics in microbiology and immunology.